Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure

被引:157
作者
Asayama, Kei [2 ]
Ohkubo, Takayoshi [3 ]
Metoki, Hirohito [4 ]
Obara, Taku [4 ]
Inoue, Ryusuke [5 ]
Kikuya, Masahiro
Thijs, Lutgarde [2 ]
Staessen, Jan A. [2 ,6 ]
Imai, Yutaka [1 ]
机构
[1] Tohoku Univ, Dept Planning Drug Dev & Clin Evaluat, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Univ Louvain, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis, Louvain, Belgium
[3] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan
[4] Tohoku Univ, Grad Sch Med, Dept Dev & Environm Med, Sendai, Miyagi 980, Japan
[5] Tohoku Univ, Grad Sch Med, Dept Med Informat, Sendai, Miyagi 980, Japan
[6] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
关键词
antihypertensive drug treatment; blood pressure control; home blood pressure; randomized clinical trial; ISOLATED SYSTOLIC HYPERTENSION; RISK; OFFICE; PHYSICIANS; SOCIETY; STROKE; CLASSIFICATION; THRESHOLDS; GUIDELINES; MONITOR;
D O I
10.1038/hr.2012.125
中图分类号
R6 [外科学];
学科分类号
100210 [外科学];
摘要
Hypertension guidelines recommend blood pressure self-measurement at home (HBP), but no previous trial has assessed cardiovascular outcomes in hypertensive patients treated according to HBP. The multicenter Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP; 2001-2010) trial involved 3518 patients (50% women; mean age 59.6 years) with an untreated systolic/diastolic HBP of 135-179/85-119 mm Hg. In a 2 x 3 design, patients were randomized to usual control (125-134/80-84 mm Hg (UC)) vs. tight control (<125/<80 mm Hg (TC)) of HBP and to initiation of drug treatment with angiotensin converting enzyme inhibitors, angiotensin receptor blockers or calcium channel blockers. During follow-up, a computer algorithm automatically generated treatment recommendations based on HBP. At the last follow-up (median 5.3 years), TC patients used more antihypertensive drugs than UC patients (1.82 vs. 1.74 defined daily doses, P = 0.045) and had a greater HBP reduction (21.3/13.1 mm Hg vs. 22.7/13.9 mm Hg, P = 0.018/0.020), but they less frequently achieved the lower HBP targets (37.4 vs. 63.5%, P<0.0001). The primary end point, cardiovascular death plus stroke and myocardial infarction, occurred in 25 UC and 26 TC patients (hazard ratio, 1.02; 95% confidence interval, 0.59-1.77; P = 0.94). Rates were similar (P >= 0.13) in the three drug groups. In all patients combined, the risk of the primary end point independently increased by 41% (6-89%; P = 0.019) and 47% (15-87%; P = 0.0020) for a 1-s.d. increase in baseline (12.5 mm Hg) and follow-up (13.2 mm Hg) systolic HBP. The 5-year risk was minimal (<= 1%) if on-treatment systolic HBP was 131.6 mm Hg or less. HOMED-BP proved the feasibility of adjusting antihypertensive drug treatment based on HBP and suggests that a systolic HBP level of 130 mm Hg should be an achievable and safe target. Hypertension Research (2012) 35, 1102-1110; doi:10.1038/hr.2012.125; published online 16 August 2012
引用
收藏
页码:1102 / 1110
页数:9
相关论文
共 41 条
[1]
[Anonymous], 1997, Cardiovasc Res, V35, P2
[2]
[Anonymous], ATC/DDD Index 2019
[3]
[Anonymous], 2005, INTRO PRACTICE STAT
[4]
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413
[5]
Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification - The Ohasama study [J].
Asayama, K ;
Ohkubo, T ;
Kikuya, M ;
Metoki, H ;
Hoshi, H ;
Hashimoto, J ;
Totsune, K ;
Satoh, H ;
Imai, Y .
STROKE, 2004, 35 (10) :2356-2361
[6]
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis [J].
Bhatt, Deepak L. ;
Eagle, Kim A. ;
Ohman, E. Magnus ;
Hirsch, Alan T. ;
Goto, Shinya ;
Mahoney, Elizabeth M. ;
Wilson, Peter W. F. ;
Alberts, Mark J. ;
D'Agostino, Ralph ;
Liau, Chiau-Suong ;
Mas, Jean-Louis ;
Roether, Joachim ;
Smith, Sidney C., Jr. ;
Salette, Genevieve ;
Contant, Charles F. ;
Massaro, Joseph M. ;
Steg, Ph. Gabriel .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (12) :1350-1357
[7]
Chalmers J, 1999, J HYPERTENS, V17, P151
[8]
Device for the self-measurement of blood pressure that can monitor blood pressure during sleep [J].
Chonan, K ;
Kikuya, M ;
Araki, T ;
Fujiwara, T ;
Suzuki, M ;
Michimata, M ;
Hashimoto, J ;
Ohkubo, T ;
Hozawa, A ;
Yamamoto, N ;
Miyawaki, Y ;
Matsubara, M ;
Imai, Y .
BLOOD PRESSURE MONITORING, 2001, 6 (04) :203-205
[9]
Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries [J].
Ferrari, P. .
JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (03) :151-159
[10]
Franklin SS, 2001, CIRCULATION, V103, P1245